leadf
logo-loader
RNS
viewRex Bionics PLC

Rex Bionics PLC - Holdings in Company

RNS Number : 2341G
Rex Bionics PLC
25 May 2017
 

 

For filings with the FCA include the annex


For filings with issuer exclude the annex



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

REX BIONICS PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):



3. Full name of person(s) subject to the
notification obligation:
iii

DHRUPA PATEL

4. Full name of shareholder(s)
 (if different from 3.):iv

MARK BRADSHAW

5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

23rd MAY, 2017

 

6. Date on which issuer notified:

23rd MAY, 2017

 

7. Threshold(s) that is/are crossed or
reached:
vi, vii

12%



 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

GB00BLRLQM66

0

0

3,172,450

3,172,450


12.43%




B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 





 

 

Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,172,450

12.43%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

 

Mark Bradshaw controls 3,172,450 shares and 1,420,887 shares via Bradshaw Asset Management Limited directly. Bradshaw Asset Management is also investment advisor to Victory Special Opportunities Fund, a cell of Freedom Global Funds PLC which owns 477,778 shares and 100,000 Warrants issued on 1st August 2016.


Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A



13. Additional information:



14. Contact name:

DHRUPA PATEL

15. Contact telephone number:

0207 250 4350



 

Note: Annex should only be submitted to the FCA not the issuer

Annex: Notification of major interests in share


A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 

MARK BRADSHAW

Contact address

(registered office for legal entities)

 

10-11 CHARTERHOUSE SQUARE

LONDON

EC1M 6EE

Phone number & email

 

0207 250 4350

[email protected]

Other useful information

(at least legal representative for legal persons)

 




B: Identity of the notifier, if applicable

Full name

 

DHRUPA PATEL

Contact address

 

10-11 CHARTERHOUSE SQUARE

LONDON

EC1M 6EE

Phone number & email

 

0207 250 4350

[email protected]

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

COMPLIANCE OFFICER

BRADSHAW ASSET MANAGEMENT


C: Additional information


For notes on how to complete form TR-1 please see the FCA website.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLIFVAETIEFID

Quick facts: Rex Bionics PLC

Price: -

Market: AIM
Market Cap: -
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

6 min read